Longevity Health Holdings Profit Margin

The latest profit margin for XAGE is -404.84% as of June 2026. That compares with -115.81% in the prior-year period — down 249.6% year over year. That is below the sector sector average of 13.2%. Investors often review this figure alongside Longevity Health Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, XAGE's profit margin moved from -115.81% to -404.84% — a 249.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Longevity Health Holdings's valuation or profitability profile.

Against its sector companies, XAGE currently prints -404.84% for profit margin, while the sector average sits near 13.2%. That is roughly 3167.2% below the sector mean. Large gaps often invite a closer look at Longevity Health Holdings's growth, margins, and balance sheet.

Profit Margin shows how effectively Longevity Health Holdings converts resources into returns. At -404.84%, XAGE may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -115.81% in the prior-year period — down 249.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting XAGE's profit margin (-404.84%), review year-over-year change from -115.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.